Pomalidomide with bortezomib and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)

Technology appraisal
Reference number: TA602
Published: 25 September 2019

History

Invitation to participate

Final scope (PDF 323 KB)

Published:

04 October 2018
Final matrix (PDF 303 KB)

Published:

05 October 2018
NICE's response to comments on the draft scope and provisional matrix (PDF 179 KB)

Published:

08 October 2018
Equality impact assessment (Scoping) (PDF 178 KB)

Published:

08 October 2018

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope post referral (PDF 322 KB)

Published:

18 July 2018
Draft matrix post referral (PDF 304 KB)

Published:

18 July 2018